Bpifrance Participations SA

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Bpifrance Participations SA's trades of Innate Pharma SA's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
233.02
Quantity 83,479
Value €4,645,246
Transaction date
Sale
Price
386.06
Quantity 99,160
Value €134,541
FR Frey SA (FREY)
Transaction date
Purchase
Price
443.03
Quantity 3,760
Value €4,538,844
Transaction date
Proposed sale
Price
33.24
Quantity 2,095,000
Value US$69,637,800
Transaction date
Proposed sale
Price
33.24
Quantity 2,095,000
Value US$69,637,800
Transaction date
Proposed sale
Price
21.67
Quantity 1,900,000
Value US$41,173,000
Transaction date
Proposed sale
Price
21.67
Quantity 1,900,000
Value US$41,173,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-14 2026-08-14 B Purchase
83,479
233.02
€4,645,246
83,479 233.02 €4,645,246
2026-08-04 2026-07-31 S Sale
99,160
386.06
€134,541
99,160 386.06 €134,541
2026-06-22 2026-06-18
FR Frey SA (FREY)
B Purchase
3,760
443.03
€4,538,844
3,760 443.03 €4,538,844
2026-05-26 2026-05-26 PrS Proposed sale
2,095,000
33.24
US$69,637,800
2,095,000 33.24 US$69,637,800
2026-05-26 2026-05-26 PrS Proposed sale
2,095,000
33.24
US$69,637,800
2,095,000 33.24 US$69,637,800
2024-06-04 2024-06-05 PrS Proposed sale
1,900,000
21.67
US$41,173,000
1,900,000 21.67 US$41,173,000
2024-06-04 2024-06-05 PrS Proposed sale
1,900,000
21.67
US$41,173,000
1,900,000 21.67 US$41,173,000